chr16-7710640-G-C
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018723.4(RBFOX1):c.1089G>C(p.Leu363Phe) variant causes a missense change. The variant allele was found at a frequency of 0.000000684 in 1,461,082 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. L363L) has been classified as Likely benign.
Frequency
Consequence
NM_018723.4 missense
Scores
Clinical Significance
Conservation
Publications
- epilepsyInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- neurodevelopmental disorderInheritance: AD Classification: LIMITED Submitted by: G2P
- autism susceptibility 1Inheritance: Unknown Classification: LIMITED Submitted by: Laboratory for Molecular Medicine
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RBFOX1 | ENST00000550418.6 | c.1089G>C | p.Leu363Phe | missense_variant | Exon 16 of 16 | 1 | NM_018723.4 | ENSP00000450031.1 | ||
| RBFOX1 | ENST00000355637.9 | c.*17G>C | 3_prime_UTR_variant | Exon 14 of 14 | 1 | NM_145893.3 | ENSP00000347855.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000399 AC: 1AN: 250478 AF XY: 0.00000739 show subpopulations
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461082Hom.: 0 Cov.: 34 AF XY: 0.00000138 AC XY: 1AN XY: 726860 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1152G>C (p.L384F) alteration is located in exon 13 (coding exon 13) of the RBFOX1 gene. This alteration results from a G to C substitution at nucleotide position 1152, causing the leucine (L) at amino acid position 384 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Idiopathic generalized epilepsy Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with RBFOX1-related disease. This variant is present in population databases (rs776822373, ExAC 0.001%). This sequence change replaces leucine with phenylalanine at codon 384 of the RBFOX1 protein (p.Leu384Phe). The leucine residue is weakly conserved and there is a small physicochemical difference between leucine and phenylalanine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at